Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IOngoingD-0211-2025

Drug recall · February 5, 2025

Prograf recall

Why: Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.

Lots / codes

Lot# 0E3353D, Exp 03/31/2026

Quantity
14,340 100-count bottles
Company
Astellas Pharma US Inc., Northbrook, IL
Distribution
Nationwide in the USA
Initiated
December 23, 2024 · Voluntary: Firm initiated
Classified
January 29, 2025
Reported
February 5, 2025
How notified
Press Release

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Prograf

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.